{"id":56227,"date":"2023-04-26T12:03:18","date_gmt":"2023-04-26T10:03:18","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/"},"modified":"2023-04-26T12:03:18","modified_gmt":"2023-04-26T10:03:18","slug":"vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/","title":{"rendered":"Vektor Medical Welcomes Two New Advisors to Advance Technology and Commercial Development"},"content":{"rendered":"<div>\n<p>SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/arrhythmias?src=hash\" target=\"_blank\" rel=\"noopener\">#arrhythmias<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vektormedical.com%2F&amp;esheet=53388097&amp;newsitemid=20230426005463&amp;lan=en-US&amp;anchor=Vektor+Medical&amp;index=1&amp;md5=1fa48e05444fe89a3486dca9becfa0fa\" rel=\"nofollow noopener\" shape=\"rect\">Vektor Medical<\/a>, developer of the vMap\u00ae next-generation arrhythmia mapping technology, today announced former Philips and Biotronik medical technology leader Marlou Janssen and Yale Clinical Professor of Medicine and past American College of Cardiology (ACC) Connecticut Chapter Governor and President Dr. Craig McPherson have joined Vektor\u2019s advisory board.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230426005463\/en\/1774995\/5\/Vektor_Medical_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230426005463\/en\/1774995\/21\/Vektor_Medical_Logo.jpg\"><\/a><\/p>\n<p>\nWith more than two decades of experience leading medical device teams for medtech companies across the globe (including Philips, Biotronik, and St. Jude Medical), Mrs. Janssen brings strong business acumen and extensive understanding of the worldwide healthcare markets, delivering value-based customer-focused medical solutions globally. She has proven expertise in introducing growth-oriented strategies, successfully executing sales and marketing plans, and directly managing high-performing cross-functional teams within large- and medium-sized organizations. Throughout her career, she has pioneered and launched several industry-first innovations. She will support Vektor in its commercial development, growth planning, and leadership development.<\/p>\n<p>\n\u201c<!-- no quote -->I\u2019m thrilled to be joining Vektor\u2019s advisory board to assist the team in the commercial roll-out of vMap. I believe Vektor\u2019s technology is poised to disrupt the market and greatly enhance the care of individuals affected by cardiac arrhythmias. I\u2019m incredibly impressed by what their lean team has achieved to date and look forward to supporting them in their strategic and clinical operations,\u201d said Mrs. Janssen.<\/p>\n<p>\nDr. McPherson is a highly respected electrophysiologist and Clinical Professor of Medicine at Yale University. With more than four decades of experience, he joins Vektor\u2019s clinical advisory board to share his wealth of experience and expertise with the team. He is presently the longest-serving cardiology program director in the U.S. and served as chapter president and representative to the ACC\u2019s Board of Governors from 2020-2023. He has also served as the co-chair of the Institutional Review Board and member of the Nominating Committee and the Graduate Medical Education Committee.<\/p>\n<p>\n\u201c<!-- no quote -->From my initial meeting with the Vektor team, it was immediately apparent to me that they have developed an exceptional technology with the potential to revolutionize the treatment of arrhythmias and significantly enhance patient outcomes,\u201d said Dr. McPherson. \u201c<!-- no quote -->I\u2019m excited to support Vektor in furthering their mission and leverage my expertise to increase awareness of Vektor\u2019s groundbreaking solution.\u201d<\/p>\n<p>\n\u201c<!-- no quote -->We are honored to welcome Marlou Janssen and Dr. Craig McPherson to our clinical advisory board. With their exceptional medical expertise and vast experience in electrophysiology, we are confident that they will provide invaluable insights and guidance to our team,\u201d said Rob Krummen, CEO of Vektor Medical. \u201c<!-- no quote -->Both of these exemplary leaders are acutely aware of the need for new technologies that can safely and effectively improve treatment for the millions of people suffering from arrhythmias. We are delighted they have chosen to join Vektor Medical\u2019s effort to drastically improve cardiac care.\u201d<\/p>\n<p>\n<b>About vMap\u00ae<\/b><\/p>\n<p>\nvMap\u00ae is a next-generation, FDA-cleared technology that enables rapid and non-invasive mapping of arrhythmia sources for focal or fibrillation-type arrhythmias in all four chambers of the heart, with 97.3% accuracy. vMap utilizes advanced machine learning techniques and proprietary computational models to extract valuable information from a standard 12-lead ECG, providing functional insights into the location of arrhythmia sources. The goal of vMap is to improve medicine by optimizing our understanding of arrhythmias and improving ablations by accurately identifying the sources of those arrhythmias.<\/p>\n<p>\n<b>About Vektor Medical<\/b><\/p>\n<p>\nSan Diego-based <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vektormedical.com%2F&amp;esheet=53388097&amp;newsitemid=20230426005463&amp;lan=en-US&amp;anchor=Vektor+Medical&amp;index=2&amp;md5=2bf7092695cc139d448e00ca6158ea57\" rel=\"nofollow noopener\" shape=\"rect\">Vektor Medical<\/a> is committed to enhancing arrhythmia care for the millions of individuals affected by atrial fibrillation and other arrhythmias. Through its non-invasive cardiac arrhythmia technology, vMap, the company aims to enhance the success rate of first-pass ablation, reduce the risks associated with invasive mapping, and shorten procedure times. These advancements are expected to result in better outcomes for patients and a decrease in healthcare costs related to ablation procedures.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nAnnika Parrish<br \/>\n<br \/>Health+Commerce<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;lt&#x6f;&#x3a;&#97;&#110;n&#x69;&#x6b;&#97;&#64;h&#x65;&#x61;&#x6c;&#116;ha&#x6e;&#x64;&#99;&#111;m&#x6d;&#x65;&#114;&#99;e&#x2e;&#x63;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x61;&#110;n&#x69;&#107;a&#x40;&#104;e&#x61;&#108;t&#x68;&#97;n&#x64;&#x63;o&#x6d;&#x6d;&#101;&#x72;&#x63;&#101;&#x2e;&#x63;&#111;m<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;#arrhythmias&#8212;Vektor Medical, developer of the vMap\u00ae next-generation arrhythmia mapping technology, today announced former Philips and Biotronik medical technology leader Marlou Janssen and Yale Clinical Professor of Medicine and past American College of Cardiology (ACC) Connecticut Chapter Governor and President Dr. Craig McPherson have joined Vektor\u2019s advisory board. With more than two decades of &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56227","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vektor Medical Welcomes Two New Advisors to Advance Technology and Commercial Development - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vektor Medical Welcomes Two New Advisors to Advance Technology and Commercial Development - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;#arrhythmias&#8212;Vektor Medical, developer of the vMap\u00ae next-generation arrhythmia mapping technology, today announced former Philips and Biotronik medical technology leader Marlou Janssen and Yale Clinical Professor of Medicine and past American College of Cardiology (ACC) Connecticut Chapter Governor and President Dr. Craig McPherson have joined Vektor\u2019s advisory board. With more than two decades of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-26T10:03:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230426005463\/en\/1774995\/21\/Vektor_Medical_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Vektor Medical Welcomes Two New Advisors to Advance Technology and Commercial Development\",\"datePublished\":\"2023-04-26T10:03:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\\\/\"},\"wordCount\":640,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230426005463\\\/en\\\/1774995\\\/21\\\/Vektor_Medical_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\\\/\",\"name\":\"Vektor Medical Welcomes Two New Advisors to Advance Technology and Commercial Development - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230426005463\\\/en\\\/1774995\\\/21\\\/Vektor_Medical_Logo.jpg\",\"datePublished\":\"2023-04-26T10:03:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230426005463\\\/en\\\/1774995\\\/21\\\/Vektor_Medical_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230426005463\\\/en\\\/1774995\\\/21\\\/Vektor_Medical_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vektor Medical Welcomes Two New Advisors to Advance Technology and Commercial Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vektor Medical Welcomes Two New Advisors to Advance Technology and Commercial Development - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/","og_locale":"en_US","og_type":"article","og_title":"Vektor Medical Welcomes Two New Advisors to Advance Technology and Commercial Development - Pharma Trend","og_description":"SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;#arrhythmias&#8212;Vektor Medical, developer of the vMap\u00ae next-generation arrhythmia mapping technology, today announced former Philips and Biotronik medical technology leader Marlou Janssen and Yale Clinical Professor of Medicine and past American College of Cardiology (ACC) Connecticut Chapter Governor and President Dr. Craig McPherson have joined Vektor\u2019s advisory board. With more than two decades of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-26T10:03:18+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230426005463\/en\/1774995\/21\/Vektor_Medical_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Vektor Medical Welcomes Two New Advisors to Advance Technology and Commercial Development","datePublished":"2023-04-26T10:03:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/"},"wordCount":640,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230426005463\/en\/1774995\/21\/Vektor_Medical_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/","url":"https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/","name":"Vektor Medical Welcomes Two New Advisors to Advance Technology and Commercial Development - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230426005463\/en\/1774995\/21\/Vektor_Medical_Logo.jpg","datePublished":"2023-04-26T10:03:18+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230426005463\/en\/1774995\/21\/Vektor_Medical_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230426005463\/en\/1774995\/21\/Vektor_Medical_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/vektor-medical-welcomes-two-new-advisors-to-advance-technology-and-commercial-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Vektor Medical Welcomes Two New Advisors to Advance Technology and Commercial Development"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56227","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56227"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56227\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56227"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56227"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56227"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}